Question 1

Has David Dulaney received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $144,679 in general payments to David Dulaney across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean David Dulaney did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about David Dulaney come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	38	$33,929
Regeneron Healthcare Solutions, Inc.	35	$28,943
Regeneron	8	$27,999
Sanofi	19	$25,956
Lilly USA, LLC	38	$25,098
Bristol Myers Squibb	11	$859
AbbVie	11	$802
Intercept Pharmaceuticals, Inc.	2	$238
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$184
Medtronic	1	$148
Phathom Pharmaceuticals, Inc.	2	$131
Olympus America Inc.	4	$125
La Jolla Pharmaceutical Company	1	$118
Pfizer	1	$81
Alnylam Pharmaceuticals Inc.	1	$44
Merck	1	$24

David Dulaney

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other gastroenterology in Jbsa Ft Sam Houston